Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0PQ8B
|
|||
Former ID |
DNC003913
|
|||
Drug Name |
3-Decanoyl-4-hydroxy-6-nonyl-pyran-2-one
|
|||
Synonyms |
CHEMBL7958; 3-Decanoyl-4-hydroxy-6-nonyl-pyran-2-one; SCHEMBL10337595
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C24H40O4
|
|||
Canonical SMILES |
CCCCCCCCCC1=CC(=C(C(=O)O1)C(=O)CCCCCCCCC)O
|
|||
InChI |
1S/C24H40O4/c1-3-5-7-9-11-13-15-17-20-19-22(26)23(24(27)28-20)21(25)18-16-14-12-10-8-6-4-2/h19,26H,3-18H2,1-2H3
|
|||
InChIKey |
FFXYZCMDXPBYIG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Neutrophil elastase (NE) | Target Info | Inhibitor | [1] |
KEGG Pathway | Transcriptional misregulation in cancer | |||
Systemic lupus erythematosus | ||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||
C-MYB transcription factor network | ||||
Reactome | Collagen degradation | |||
Degradation of the extracellular matrix | ||||
Activation of Matrix Metalloproteinases | ||||
WikiPathways | Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||
Human Complement System | ||||
Degradation of collagen |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibition of human sputum elastase by substituted 2-pyrones. J Med Chem. 1987 Jun;30(6):1017-23. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.